ISRCTN ISRCTN83103698
DOI https://doi.org/10.1186/ISRCTN83103698
Protocol serial number G108/374
Sponsor University of Manchester (UK)
Funder National Institute of Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB)
Submission date
07/01/2003
Registration date
07/01/2003
Last edited
03/10/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr S Hamdy
Scientific

GI Sciences
Hope Hospital
Eccles Old Road
Salford
M6 8HD
United Kingdom

Phone +44 (0)161 787 4414
Email Shaheen.hamdy@manchester.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA randomised controlled trial of pharyngeal electrical stimulation in the treatment of dysphagia after brain injury
Study objectivesEstablish efficacy of pharyngeal stimulation in accelerating swallowing recovery after acute dysphagic stroke.

On 22/07/2008 the following changes were made to the trial record:
1. The anticipated start date was changed from 01/09/2003 to 08/11/2005.
2. The anticipated end date was changed from 31/08/2005 to 31/11/2013.
3. The sources of funding field was changed from 'Medical Research Council (UK) and The Health Foundation (UK) (ref: 1727/1793)' to 'Action Medical Research (UK) (until April 2009) and National Institute of Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB)'.

On 15/10/2009 the following changes were made to the trial record:
1. The scientific title was added.
2. The sources of funding field was changed from 'Action Medical Research (UK) (until April 2009) and National Institute of Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB) ' to 'National Institute of Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB)'.
Ethics approval(s)Salford and Trafford Research Ethics Committee, 01/10/2002, ref: 00167. An ethics amendment for the current phase of the study was approved on 08/11/2005.
Health condition(s) or problem(s) studiedAcute dysphagic stroke
InterventionCurrent interventions as of 05/09/2008:
Subjects are randomised to receive either real or sham pharyngeal electrical stimulation at low frequency. The intensity of the electrical stimulation is determined following the calculation of suitable sensory threshold, tailored to the individual participants. Subjects receive the intervention three times in a week, within a few days following index videofluoroscopy.

Previous interventions:
Real versus sham stimulation

The previous sponsor for this trial (from 01/09/2005 to 31/01/2008) was:
Medical Research Council (UK)
20 Park Crescent
London
W1B 1AL
United Kingdom
Intervention typeOther
Primary outcome measure(s)

Current primary outcome measures as of 05/09/2008:
Penetration-aspiration score and swallowing response time, assessed by videofluoroscopy at baseline and 2 weeks after the intervention.

Previous primary outcome measures:
1. Mortality
2. Aspiration pneumonia
3. Swallowing function assessed by videofluoroscopy

Key secondary outcome measure(s)

Added as of 05/09/2008:
1. Aspiration pneumonia rates
2. Usage of antibiotics for chest infections
3. Hospital stays
4. Readmission rates
5. Mortality

Total duration of follow-up: 6 months

Completion date30/11/2013

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration80
Key inclusion criteriaCurrent inclusion criteria as of 05/09/2008:
Any patient with first event of an anterior circulation stroke (both males and females, no age limits). Patients are recruited within 3 weeks of their admission with stroke. Videofluoroscopy is carried out to determine the degree of airway penetration/aspiration.

Previous inclusion criteria:
Hemispheric stroke and dysphagia
Key exclusion criteria1. Inability to give informed consent
2. Serious inter-current illness
3. Major neuromuscular modulating drugs
4. Other neurological diseases
5. Previous dysphagia
Date of first enrolment08/11/2005
Date of final enrolment30/11/2013

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

GI Sciences
Salford
M6 8HD
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Abstract results abstract from Annual Meeting of the American Gastroenterological Association/Digestive Disease Week: 01/04/2005 No No
Abstract results abstract from Annual Meeting of the British Society of Gastroenterology: 01/04/2006 No No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes